Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomised trial
- PMID: 10759273
- DOI: 10.1111/j.1471-0528.2000.tb13273.x
Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomised trial
Abstract
Objectives: To compare the efficacy of two different regimens of mifepristone followed by misoprostol for medical abortion in women with menstrual delay of < or = 35 days.
Design: Double-blind, randomised controlled trial.
Setting: Seventeen centres internationally.
Participants: We enrolled 1,589 healthy pregnant women with menstrual delay of < or = 35 days who were requesting nonsurgical abortion.
Interventions: Within gestational age strata, we randomly assigned women to receive a single oral dose of mifepristone, either 200 mg or 600 mg, followed in 48 h by misoprostol 400 microg by mouth. We concealed the allocation assignments from investigators and participants and maintained double-blinding throughout the study.
Main outcome measures: Complete abortion was the principal outcome measure. We also compared rates of side effects such as abdominal pain.
Results: The complete abortion rate with the lower dose of mifepristone was similar to that with the higher dose (89.3% vs 88.1%) The crude relative risk of failure to achieve complete abortion with the 200 mg dose compared with the 600 mg dose was 0.9 (95% CI 0.7 to 1.2). The likelihood of complete abortion was inversely related to gestational age, although this finding is exploratory in nature. Among failures the percentage of women with continuing pregnancies increased from 1.4% at menstrual delay of two weeks or less to 9.0% when the delay was 4-5 weeks. Low efficacy led to stopping enrolment at 29 to 35 days' menstrual delay. Stopping criteria were also met at completion of the study in the group with 22-28 days' menstrual delay. No significant differences emerged in the frequency of side effects between the two mifepristone groups.
Conclusions: Both regimens had similar efficacy. Women with a menstrual delay of four to five weeks had twice the risk of failure to abort compared with those who received treatment within two weeks of the expected menses. The efficacy of the mifepristone-prostaglandin regimen was not reduced by decreasing the dose of mifepristone from 600 mg to 200 mg. The regimens of 600 mg or 200 mg of mifepristone, followed by a single oral dose of misoprostol 400 microg 48 hours later, were not sufficiently efficient in inducing abortion when the menstrual delay was > 21 days.
Similar articles
-
Low-dose mifepristone 200 mg and vaginal misoprostol for abortion.Contraception. 1999 Jan;59(1):1-6. doi: 10.1016/s0010-7824(98)00150-4. Contraception. 1999. PMID: 10342079 Clinical Trial.
-
Randomized, double-blind, controlled trial of mifepristone in capsule versus tablet form followed by misoprostol for early medical abortion.Eur J Obstet Gynecol Reprod Biol. 2004 Oct 15;116(2):211-6. doi: 10.1016/j.ejogrb.2003.12.024. Eur J Obstet Gynecol Reprod Biol. 2004. PMID: 15358467 Clinical Trial.
-
Randomized trial of oral versus vaginal misoprostol 2 days after mifepristone 200 mg for abortion up to 63 days of pregnancy.Contraception. 2002 Oct;66(4):247-50. doi: 10.1016/s0010-7824(02)00366-9. Contraception. 2002. PMID: 12413620 Clinical Trial.
-
Medical methods for first trimester abortion.Cochrane Database Syst Rev. 2004;(1):CD002855. doi: 10.1002/14651858.CD002855.pub2. Cochrane Database Syst Rev. 2004. Update in: Cochrane Database Syst Rev. 2004;(2):CD002855. doi: 10.1002/14651858.CD002855.pub3. PMID: 14973995 Updated. Review.
-
Cervical preparation for first trimester surgical abortion.Cochrane Database Syst Rev. 2010 Feb 17;(2):CD007207. doi: 10.1002/14651858.CD007207.pub2. Cochrane Database Syst Rev. 2010. PMID: 20166091 Review.
Cited by
-
A prospective study on the effectiveness of a combination regime (Mifepristone and Misoprostol) in comparison with Misoprostol for missed abortion.J Family Med Prim Care. 2023 Oct;12(10):2423-2427. doi: 10.4103/jfmpc.jfmpc_503_23. Epub 2023 Oct 11. J Family Med Prim Care. 2023. PMID: 38074237 Free PMC article.
-
Short-term efficacy and safety of early medical abortion in Japan: A multicenter prospective study.Reprod Med Biol. 2023 Mar 31;22(1):e12512. doi: 10.1002/rmb2.12512. eCollection 2023 Jan-Dec. Reprod Med Biol. 2023. PMID: 37013166 Free PMC article.
-
Post-abortion Complications: A Narrative Review for Emergency Clinicians.West J Emerg Med. 2022 Oct 23;23(6):919-925. doi: 10.5811/westjem.2022.8.57929. West J Emerg Med. 2022. PMID: 36409940 Free PMC article. Review.
-
Medical methods for first trimester abortion.Cochrane Database Syst Rev. 2022 May 24;5(5):CD002855. doi: 10.1002/14651858.CD002855.pub5. Cochrane Database Syst Rev. 2022. PMID: 35608608 Free PMC article. Review.
-
Pain management for medical abortion before 14 weeks' gestation.Cochrane Database Syst Rev. 2022 May 13;5(5):CD013525. doi: 10.1002/14651858.CD013525.pub2. Cochrane Database Syst Rev. 2022. PMID: 35553047 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous